RE: Epigenetic profiling and response to CD19 chimeric antigen receptor T-cell therapy in B-cell malignancies

J Natl Cancer Inst. 2023 Oct 9;115(10):1231-1233. doi: 10.1093/jnci/djad165.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antigens, CD19
  • Cell- and Tissue-Based Therapy
  • Epigenesis, Genetic
  • Humans
  • Immunotherapy, Adoptive
  • Neoplasms*
  • Receptors, Antigen, T-Cell / genetics
  • Receptors, Chimeric Antigen* / genetics
  • T-Lymphocytes

Substances

  • Receptors, Chimeric Antigen
  • Antigens, CD19
  • Receptors, Antigen, T-Cell